Market Cap

Immunocore Holdings plc Market Capitalization:

$1.71 Billion

USD as of Jan. 1, 2026

business Immunocore Holdings plc Company Profile

Immunocore Holdings plc Main Stock Listing

NASDAQ: IMCR

Market Capitalization History of Immunocore Holdings plc

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Immunocore Holdings plc market cap

Date Market Cap YoY Change
Jan. 1, 2026 $1.71 B 20.44%
Jan. 1, 2025 $1.42 B -56.93%
Jan. 1, 2024 $3.29 B 26.25%
Jan. 1, 2023 $2.61 B 153.19%
Jan. 1, 2022 $1.03 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Immunocore Holdings plc Categories

United Kingdom languages Healthcare languages Biotechnology
United Kingdom Healthcare United Kingdom Biotechnology

Stocks & Indices

Immunocore Holdings plc has the following listings and related stock indices.


Stock: NASDAQ: IMCR

Stock: FSX: 6YG

Stock: Munich: 6YG

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.